Loading
Life sciences · Journal article
Journal of Translational Medicine · August 13, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that synthesizes current understanding of mitochondrial regulation across multiple cell death pathways (apoptosis, necroptosis, pyroptosis) and integrates the recently identified mitoxyperiosis pathway into a unified conceptual framework. The work proposes mechanistic questions and therapeutic opportunities but does not present new empirical evidence or clinical outcomes.
Narrative review.
Mitochondria regulate classical programmed cell death pathways including apoptosis, necroptosis, and pyroptosis Mitoxyperiosis is identified as a BAX/BAK1/BID-dependent and spatially restricted mode of oxidative cell death Key regulatory mechanisms include mitochondrial outer membrane permeabilization, reactive oxygen species bursts, mitochondrial DNA release, and alterations in mitochondrial dynamics
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies mitochondrial checkpoints as potential therapeutic targets for disease states associated with mitochondrial dysfunction and cancer. However, as a conceptual synthesis without empirical clinical data, it should be read as a framework for hypothesis generation rather than actionable clinical evidence.
This is a narrative review synthesizing existing knowledge about mitochondrial regulation of cell death and proposing a conceptual framework; it raises questions and integrates evidence rather than presenting new empirical findings or clinical outcomes.
As stated by the source record.
This review identifies mitochondrial checkpoints as potential therapeutic targets for disease states associated with mitochondrial dysfunction and cancer. However, as a conceptual synthesis without empirical clinical data, it should be read as a framework for hypothesis generation rather than actionable clinical evidence.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Mitochondria are recognized as pivotal regulators in cell fate determination, and their dysfunction is implicated in numerous major diseases. While mitochondria control classical programmed cell death pathways, including apoptosis, necroptosis, and pyroptosis, the recent identification of mitoxyperiosis, a BAX/BAK1/BID-dependent and spatially restricted mode of oxidative death, has added complexity to this regulatory framework. Nonetheless, a systematic understanding of how mitochondria coordinate these diverse pathways, particularly the mechanistic relationship between canonical death pathways and this newly identified mode, remains insufficiently explored. In this review, we address three fundamental questions: (1) Through which key molecular mechanisms, including mitochondrial outer membrane permeabilization, reactive oxygen species bursts, mitochondrial DNA release, and alterations in mitochondrial dynamics, do mitochondria regulate each major death pathway? (2) How does mitoxyperiosis diverge from and intersect with classical ferroptosis and other death modalities, and what unique features characterize its execution? (3) What therapeutic opportunities and challenges emerge from targeting mitochondrial death checkpoints to protect cells in pathological conditions and to treat cancer? By critically integrating current evidence, we propose a comprehensive framework that elucidates the regulatory logic of mitochondria-mediated cell death and underscores mitochondrial plasticity as a crucial determinant of cellular outcomes. This perspective not only clarifies the integrative role of mitochondria within the cell death network but also suggests new avenues for developing precision therapies for diseases associated with mitochondrial dysfunction.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.